24SP
Human KRAS WT (GDP-bound) in complex with macrocyclic peptide inhibitor AP6296
This is a non-PDB format compatible entry.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | SPRING-8 BEAMLINE BL45XU |
| Synchrotron site | SPring-8 |
| Beamline | BL45XU |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2024-11-06 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 0.99999 |
| Spacegroup name | P 1 |
| Unit cell lengths | 41.430, 45.025, 57.779 |
| Unit cell angles | 87.21, 89.83, 65.79 |
Refinement procedure
| Resolution | 57.700 - 1.450 |
| R-factor | 0.1944 |
| Rwork | 0.193 |
| R-free | 0.22480 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Data reduction software | XDS (Jan 31, 2020) |
| Data scaling software | Aimless (0.7.15) |
| Phasing software | PHASER (2.8.3) |
| Refinement software | PHENIX (1.21.2_5419) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 57.700 | 57.700 | 1.774 |
| High resolution limit [Å] | 1.445 | 5.076 | 1.445 |
| Rmerge | 0.072 | 0.041 | 0.509 |
| Rmeas | 0.102 | 0.057 | 0.715 |
| Rpim | 0.071 | 0.040 | 0.502 |
| Total number of observations | 58900 | 3013 | 3014 |
| Number of reflections | 31129 | 1556 | 1556 |
| <I/σ(I)> | 3.4 | 5.53 | 1.68 |
| Completeness [%] | 83.5 | 99.3 | 33 |
| Completeness (spherical) [%] | 45.7 | 99.3 | 5.0 |
| Completeness (ellipsoidal) [%] | 83.5 | 99.3 | 33.0 |
| Redundancy | 1.89 | 1.94 | 1.94 |
| CC(1/2) | 0.988 | 0.992 | 0.600 |
| Anomalous completeness (spherical) | 30.2 | 85.8 | 1.4 |
| Anomalous completeness | 55.3 | 85.8 | 9.4 |
| Anomalous redundancy | 1.0 | 1.0 | 1.1 |
| CC(ano) | 0.000 | 0.000 | 0.000 |
| |DANO|/σ(DANO) | 0.4 | 0.3 | 0.5 |
| Diffraction limits | Principal axes of ellipsoid fitted to diffraction cut-off surface |
| 1.714 Å | 0.775, 0.775, 0.775 |
| 2.153 Å | -0.397, -0.397, -0.397 |
| 1.512 Å | -0.492, -0.492, -0.492 |
| Criteria used in determination of diffraction limits | local <I/sigmaI> ≥ 1.2 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 293 | 0.2M Magnesium chloride, 0.1M Tris (pH 8.5), 25.0% (w/v) Polyethylene glycol 3350 |






